Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.
Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M. Kollman C, et al. Among authors: hassebroek a. Blood. 2016 Jan 14;127(2):260-7. doi: 10.1182/blood-2015-08-663823. Epub 2015 Nov 2. Blood. 2016. PMID: 26527675 Free PMC article.
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman S, Wingard JR, Horowitz MM, Pavletic SZ. Arora M, et al. Among authors: hassebroek a. Blood. 2011 Jun 16;117(24):6714-20. doi: 10.1182/blood-2010-12-323824. Epub 2011 Apr 14. Blood. 2011. PMID: 21493797 Free PMC article.
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.
Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ. Jacobsohn DA, et al. Among authors: hassebroek a. Blood. 2011 Oct 20;118(16):4472-9. doi: 10.1182/blood-2011-04-349068. Epub 2011 Aug 30. Blood. 2011. PMID: 21878671 Free PMC article.
Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.
Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C, Dehn J, Friedman D, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Loberiza F, Maharaj D, McCarthy P, Setterholm M, Spellman S, Trigg M, Maziarz RT, Switzer G, Lee SJ, Rizzo JD. Baker KS, et al. Among authors: hassebroek a. Biol Blood Marrow Transplant. 2009 Dec;15(12):1543-54. doi: 10.1016/j.bbmt.2009.07.023. Epub 2009 Sep 25. Biol Blood Marrow Transplant. 2009. PMID: 19896078 Free PMC article.
Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia.
Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM. Majhail NS, et al. Among authors: hassebroek a. Biol Blood Marrow Transplant. 2012 Jun;18(6):861-73. doi: 10.1016/j.bbmt.2011.10.031. Epub 2011 Oct 29. Biol Blood Marrow Transplant. 2012. PMID: 22040843 Free PMC article.
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.
Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fasth A, Hassebroek A, Ayas M, Bonfim C, O'Brien TA, Gross TG, Horwitz M, Horwitz E, Kapoor N, Kurtzberg J, Majhail N, Ringden O, Szabolcs P, Veys P, Baker KS. Eapen M, et al. Among authors: hassebroek a. Biol Blood Marrow Transplant. 2012 Sep;18(9):1438-45. doi: 10.1016/j.bbmt.2012.03.003. Epub 2012 Mar 16. Biol Blood Marrow Transplant. 2012. PMID: 22430083 Free PMC article.
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.
Boyiadzis M, Arora M, Klein JP, Hassebroek A, Hemmer M, Urbano-Ispizua A, Antin JH, Bolwell BJ, Cahn JY, Cairo MS, Cutler CS, Flowers ME, Gale RP, Herzig R, Isola LM, Jacobsohn DA, Jagasia MH, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Spellman SR, Schouten HC, Verdonck LF, Wingard JR, Weisdorf DJ, Horowitz MM, Pavletic SZ. Boyiadzis M, et al. Among authors: hassebroek a. Clin Cancer Res. 2015 May 1;21(9):2020-8. doi: 10.1158/1078-0432.CCR-14-0586. Epub 2014 Oct 27. Clin Cancer Res. 2015. PMID: 25348512 Free PMC article.
Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.
Kamani NR, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, Cowan M, Sánchez de Toledo J, Ferster A, Szabolcs P, Wingard JR, Horwitz E, Filipovich AH. Kamani NR, et al. Among authors: hassebroek a. Biol Blood Marrow Transplant. 2011 Dec;17(12):1783-9. doi: 10.1016/j.bbmt.2011.05.008. Epub 2011 May 20. Biol Blood Marrow Transplant. 2011. PMID: 21658461 Free PMC article.
Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.
Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, LeMaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P. Hari PN, et al. Among authors: hassebroek a. Biol Blood Marrow Transplant. 2010 Mar;16(3):395-402. doi: 10.1016/j.bbmt.2009.11.007. Epub 2009 Nov 14. Biol Blood Marrow Transplant. 2010. PMID: 19922808 Free PMC article.
Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.
Hahn T, McCarthy PL Jr, Hassebroek A, Bredeson C, Gajewski JL, Hale GA, Isola LM, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS. Hahn T, et al. Among authors: hassebroek a. J Clin Oncol. 2013 Jul 1;31(19):2437-49. doi: 10.1200/JCO.2012.46.6193. Epub 2013 May 28. J Clin Oncol. 2013. PMID: 23715573 Free PMC article.
25 results